

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | production of molecular mediator involved in inflammatory response (GO:0002532) | 6.90084333 |
| 2 | positive regulation of macrophage cytokine production (GO:0060907) | 6.22052365 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.98690707 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.98690707 |
| 5 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.54238223 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.48832573 |
| 7 | T-helper 1 type immune response (GO:0042088) | 5.38108952 |
| 8 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 5.24068784 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.16413712 |
| 10 | leukocyte aggregation (GO:0070486) | 5.07176707 |
| 11 | response to peptidoglycan (GO:0032494) | 5.05177972 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 5.00524193 |
| 13 | detection of bacterium (GO:0016045) | 4.99383731 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.90135288 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.87257239 |
| 16 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.84467463 |
| 17 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.81117881 |
| 18 | negative regulation of interleukin-17 production (GO:0032700) | 4.66001833 |
| 19 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.65498837 |
| 20 | low-density lipoprotein particle remodeling (GO:0034374) | 4.59254719 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.40880722 |
| 22 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.39272752 |
| 23 | detection of external biotic stimulus (GO:0098581) | 4.32174845 |
| 24 | neutrophil activation (GO:0042119) | 4.24718124 |
| 25 | regulation of cholesterol esterification (GO:0010872) | 4.21190461 |
| 26 | regulation of macrophage cytokine production (GO:0010935) | 4.18561032 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 4.18538521 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.15423836 |
| 29 | cellular extravasation (GO:0045123) | 4.08598218 |
| 30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.08376735 |
| 31 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.05991665 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 4.05905214 |
| 33 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.05883948 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 4.02169249 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.99560951 |
| 36 | respiratory burst (GO:0045730) | 3.99184101 |
| 37 | plasma lipoprotein particle clearance (GO:0034381) | 3.97578843 |
| 38 | granulocyte activation (GO:0036230) | 3.94913988 |
| 39 | detection of biotic stimulus (GO:0009595) | 3.87989939 |
| 40 | cellular response to type I interferon (GO:0071357) | 3.87014942 |
| 41 | type I interferon signaling pathway (GO:0060337) | 3.87014942 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.86662415 |
| 43 | response to host immune response (GO:0052572) | 3.85921149 |
| 44 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.85921149 |
| 45 | response to type I interferon (GO:0034340) | 3.85386851 |
| 46 | regulation of T cell tolerance induction (GO:0002664) | 3.83740519 |
| 47 | complement activation, alternative pathway (GO:0006957) | 3.78095870 |
| 48 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.77386762 |
| 49 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.76874905 |
| 50 | phospholipid efflux (GO:0033700) | 3.74832410 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.74581878 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.71885161 |
| 53 | regulation of mast cell degranulation (GO:0043304) | 3.69038512 |
| 54 | macrophage activation (GO:0042116) | 3.67600307 |
| 55 | regulation of macrophage chemotaxis (GO:0010758) | 3.67223688 |
| 56 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.67121918 |
| 57 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.67121918 |
| 58 | positive regulation of mast cell activation (GO:0033005) | 3.66202821 |
| 59 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.64852242 |
| 60 | microglial cell activation (GO:0001774) | 3.63311650 |
| 61 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.62854504 |
| 62 | neutrophil mediated immunity (GO:0002446) | 3.58340960 |
| 63 | regulation of mast cell activation (GO:0033003) | 3.58178186 |
| 64 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.57167057 |
| 65 | positive regulation of interferon-alpha production (GO:0032727) | 3.55620444 |
| 66 | high-density lipoprotein particle remodeling (GO:0034375) | 3.54404123 |
| 67 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.51931485 |
| 68 | regulation of monocyte chemotaxis (GO:0090025) | 3.51665441 |
| 69 | I-kappaB phosphorylation (GO:0007252) | 3.48707728 |
| 70 | detection of other organism (GO:0098543) | 3.48343598 |
| 71 | response to interleukin-15 (GO:0070672) | 3.45448105 |
| 72 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.44599806 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.44487918 |
| 74 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.44307872 |
| 75 | defense response to protozoan (GO:0042832) | 3.44030469 |
| 76 | response to host (GO:0075136) | 3.41673765 |
| 77 | response to host defenses (GO:0052200) | 3.41673765 |
| 78 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.41673765 |
| 79 | pinocytosis (GO:0006907) | 3.39922439 |
| 80 | macrophage activation involved in immune response (GO:0002281) | 3.38997313 |
| 81 | regulation of mononuclear cell migration (GO:0071675) | 3.38527722 |
| 82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.36884961 |
| 83 | B cell mediated immunity (GO:0019724) | 3.35141728 |
| 84 | positive regulation by symbiont of host defense response (GO:0052509) | 3.34234840 |
| 85 | modulation by symbiont of host defense response (GO:0052031) | 3.34234840 |
| 86 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.34234840 |
| 87 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.34234840 |
| 88 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.34234840 |
| 89 | modulation by symbiont of host immune response (GO:0052553) | 3.34234840 |
| 90 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.33660742 |
| 91 | regulation of interferon-alpha production (GO:0032647) | 3.29986425 |
| 92 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.27271774 |
| 93 | reverse cholesterol transport (GO:0043691) | 3.27201022 |
| 94 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.27175600 |
| 95 | positive regulation of mast cell degranulation (GO:0043306) | 3.23819216 |
| 96 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.23819216 |
| 97 | macroautophagy (GO:0016236) | 3.21346906 |
| 98 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.21157427 |
| 99 | germinal center formation (GO:0002467) | 3.20700836 |
| 100 | macromolecular complex remodeling (GO:0034367) | 3.19853156 |
| 101 | plasma lipoprotein particle remodeling (GO:0034369) | 3.19853156 |
| 102 | protein-lipid complex remodeling (GO:0034368) | 3.19853156 |
| 103 | cellular response to interleukin-15 (GO:0071350) | 3.19742238 |
| 104 | regulation of interleukin-17 production (GO:0032660) | 3.17753505 |
| 105 | leukocyte degranulation (GO:0043299) | 3.17494579 |
| 106 | immunoglobulin mediated immune response (GO:0016064) | 3.17256419 |
| 107 | transcytosis (GO:0045056) | 3.16840951 |
| 108 | regulation of antigen processing and presentation (GO:0002577) | 3.15646823 |
| 109 | eosinophil chemotaxis (GO:0048245) | 3.15556977 |
| 110 | myeloid leukocyte mediated immunity (GO:0002444) | 3.15348418 |
| 111 | cellular response to ethanol (GO:0071361) | 3.13775532 |
| 112 | negative regulation of interleukin-6 production (GO:0032715) | 3.13519455 |
| 113 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.13058602 |
| 114 | negative regulation of innate immune response (GO:0045824) | 3.12826834 |
| 115 | positive regulation of antigen processing and presentation (GO:0002579) | 3.12016747 |
| 116 | response to muramyl dipeptide (GO:0032495) | 3.11668851 |
| 117 | negative regulation of sterol transport (GO:0032372) | 3.11589956 |
| 118 | negative regulation of cholesterol transport (GO:0032375) | 3.11589956 |
| 119 | positive regulation of cholesterol efflux (GO:0010875) | 3.11346116 |
| 120 | response to protozoan (GO:0001562) | 3.10815282 |
| 121 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.10682196 |
| 122 | interferon-gamma production (GO:0032609) | 3.09999939 |
| 123 | neutrophil activation involved in immune response (GO:0002283) | 3.09827505 |
| 124 | regulation of leukocyte degranulation (GO:0043300) | 3.09501925 |
| 125 | negative regulation of interleukin-1 production (GO:0032692) | 3.07659027 |
| 126 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.07114223 |
| 127 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.06734618 |
| 128 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.05503275 |
| 129 | regulation of neutrophil chemotaxis (GO:0090022) | 3.03586999 |
| 130 | regulation of neutrophil migration (GO:1902622) | 3.03586999 |
| 131 | cholesterol efflux (GO:0033344) | 3.01987081 |
| 132 | regulation of platelet activation (GO:0010543) | 3.01474511 |
| 133 | regulation of cholesterol storage (GO:0010885) | 3.01365730 |
| 134 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.01146498 |
| 135 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.00625344 |
| 136 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.00625344 |
| 137 | L-phenylalanine catabolic process (GO:0006559) | 3.00425141 |
| 138 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.00425141 |
| 139 | negative regulation of type 2 immune response (GO:0002829) | 2.99843575 |
| 140 | regulation of B cell differentiation (GO:0045577) | 2.99428397 |
| 141 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.99350021 |
| 142 | positive regulation of neutrophil migration (GO:1902624) | 2.99350021 |
| 143 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.97758675 |
| 144 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.97478074 |
| 145 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.96756817 |
| 146 | neutrophil chemotaxis (GO:0030593) | 2.96320020 |
| 147 | positive regulation of type 2 immune response (GO:0002830) | 2.96281624 |
| 148 | protein carboxylation (GO:0018214) | 2.95628451 |
| 149 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.95628451 |
| 150 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.95465666 |
| 151 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.95154327 |
| 152 | positive regulation of hemostasis (GO:1900048) | 2.94991577 |
| 153 | positive regulation of blood coagulation (GO:0030194) | 2.94991577 |
| 154 | positive regulation of sterol transport (GO:0032373) | 2.91888813 |
| 155 | positive regulation of cholesterol transport (GO:0032376) | 2.91888813 |
| 156 | alpha-linolenic acid metabolic process (GO:0036109) | 2.91766677 |
| 157 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.91758812 |
| 158 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.90947071 |
| 159 | myeloid leukocyte activation (GO:0002274) | 2.90514884 |
| 160 | lipoxygenase pathway (GO:0019372) | 2.89679602 |
| 161 | neutrophil migration (GO:1990266) | 2.88752298 |
| 162 | complement activation (GO:0006956) | 2.87351796 |
| 163 | positive regulation of coagulation (GO:0050820) | 2.84374178 |
| 164 | aromatic amino acid family catabolic process (GO:0009074) | 2.84162182 |
| 165 | import into cell (GO:0098657) | 2.84009202 |
| 166 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.83645003 |
| 167 | regulation of protein activation cascade (GO:2000257) | 2.81002176 |
| 168 | intestinal epithelial cell development (GO:0060576) | 2.79316870 |
| 169 | regulation of triglyceride catabolic process (GO:0010896) | 2.79147625 |
| 170 | plasma lipoprotein particle assembly (GO:0034377) | 2.77690009 |
| 171 | regulation of cholesterol metabolic process (GO:0090181) | 2.77426944 |
| 172 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.77153163 |
| 173 | bile acid biosynthetic process (GO:0006699) | 2.76745447 |
| 174 | regulation of tolerance induction (GO:0002643) | 2.75578956 |
| 175 | indolalkylamine catabolic process (GO:0046218) | 2.74533560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.00517524 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.79809298 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.67633283 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.23743708 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.81225338 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.58499198 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.53894034 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.18487576 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.16473490 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.14194832 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.04059980 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.91159806 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.72855574 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.43433419 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.36944312 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.28609721 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.26616346 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21838510 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.15911447 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.14952708 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.14070182 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.11435653 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06734400 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.03493344 |
| 25 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91521238 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.89908991 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88558333 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.82284395 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.80905329 |
| 30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.80267526 |
| 31 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.78351040 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77713244 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76647278 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.73733369 |
| 35 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.72515383 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69349443 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66212967 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65278656 |
| 39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64974459 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62457896 |
| 41 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60556347 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60216008 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56292636 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50537942 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.48653579 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46740433 |
| 47 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.46643446 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.45937663 |
| 49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44256733 |
| 50 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.42369751 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41221560 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40586036 |
| 53 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.31748976 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31593371 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31331864 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28223872 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27204544 |
| 58 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24102324 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23867751 |
| 60 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.23700458 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23612685 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21240627 |
| 63 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21029678 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20640695 |
| 65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.19323007 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18798010 |
| 67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18661083 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17597637 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17540868 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17540868 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17122953 |
| 72 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14953786 |
| 73 | MYC_22102868_ChIP-Seq_BL_Human | 1.14947042 |
| 74 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14183099 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13890694 |
| 76 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12635341 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12503074 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11861976 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10763969 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10025337 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07034434 |
| 82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04750782 |
| 83 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.04664225 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04604597 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04085228 |
| 86 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.02930581 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02806494 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02398113 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02163215 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01876601 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01697520 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00652708 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99979564 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98711600 |
| 95 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97924861 |
| 96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96828869 |
| 97 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94876043 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94709655 |
| 99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94703892 |
| 100 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92998367 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92913288 |
| 102 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92785001 |
| 103 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.91871423 |
| 104 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90123834 |
| 105 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89423201 |
| 106 | MAF_26560356_Chip-Seq_TH1_Human | 0.89282282 |
| 107 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88906115 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87921830 |
| 109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87432794 |
| 110 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86896400 |
| 111 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86198246 |
| 112 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85613356 |
| 113 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84403511 |
| 114 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.83961241 |
| 115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83311820 |
| 116 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81316631 |
| 117 | P300_27268052_Chip-Seq_Bcells_Human | 0.80665194 |
| 118 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.79991707 |
| 119 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79689191 |
| 120 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.79528160 |
| 121 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.79251071 |
| 122 | CJUN_26792858_Chip-Seq_BT549_Human | 0.78591738 |
| 123 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.77994406 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77508741 |
| 125 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.76496502 |
| 126 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.74583181 |
| 127 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.74227749 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74016152 |
| 129 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73007179 |
| 130 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.72902253 |
| 131 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72868107 |
| 132 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.72766426 |
| 133 | MYB_26560356_Chip-Seq_TH1_Human | 0.72524898 |
| 134 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.72306815 |
| 135 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.72306815 |
| 136 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.72306815 |
| 137 | GATA3_26560356_Chip-Seq_TH2_Human | 0.71249916 |
| 138 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.71221985 |
| 139 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.70677921 |
| 140 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.69748079 |
| 141 | GATA3_26560356_Chip-Seq_TH1_Human | 0.69638267 |
| 142 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69403169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.08649690 |
| 2 | MP0009840_abnormal_foam_cell | 4.63880253 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 4.10933938 |
| 4 | MP0003724_increased_susceptibility_to | 3.14619354 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.99817595 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 2.99715387 |
| 7 | MP0006082_CNS_inflammation | 2.91931572 |
| 8 | MP0003690_abnormal_glial_cell | 2.86413148 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.75904227 |
| 10 | MP0003075_altered_response_to | 2.72414563 |
| 11 | MP0005360_urolithiasis | 2.56025928 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.48962418 |
| 13 | MP0002419_abnormal_innate_immunity | 2.37426880 |
| 14 | MP0003252_abnormal_bile_duct | 2.24918632 |
| 15 | MP0009764_decreased_sensitivity_to | 2.18645938 |
| 16 | MP0002132_abnormal_respiratory_system | 2.16181751 |
| 17 | MP0000604_amyloidosis | 2.05002859 |
| 18 | MP0003436_decreased_susceptibility_to | 2.02437077 |
| 19 | MP0001790_abnormal_immune_system | 1.99186820 |
| 20 | MP0005387_immune_system_phenotype | 1.99186820 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.98737545 |
| 22 | MP0005025_abnormal_response_to | 1.97419301 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.94234433 |
| 24 | MP0000465_gastrointestinal_hemorrhage | 1.93039295 |
| 25 | MP0000685_abnormal_immune_system | 1.90913662 |
| 26 | MP0003045_fibrosis | 1.89338754 |
| 27 | MP0004510_myositis | 1.88369660 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.82648362 |
| 29 | MP0004130_abnormal_muscle_cell | 1.80166297 |
| 30 | MP0004883_abnormal_blood_vessel | 1.73105841 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.69961867 |
| 32 | MP0002398_abnormal_bone_marrow | 1.69699789 |
| 33 | MP0005365_abnormal_bile_salt | 1.66064175 |
| 34 | MP0005166_decreased_susceptibility_to | 1.63916893 |
| 35 | MP0009785_altered_susceptibility_to | 1.63823900 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.63199909 |
| 37 | MP0001853_heart_inflammation | 1.62621747 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.57050444 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.55573031 |
| 40 | MP0003828_pulmonary_edema | 1.54707819 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.54443274 |
| 42 | MP0002405_respiratory_system_inflammati | 1.54393593 |
| 43 | MP0000343_altered_response_to | 1.51707537 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.51302627 |
| 45 | MP0001800_abnormal_humoral_immune | 1.47535988 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.42512599 |
| 47 | MP0002723_abnormal_immune_serum | 1.42318091 |
| 48 | MP0005310_abnormal_salivary_gland | 1.41470637 |
| 49 | MP0003329_amyloid_beta_deposits | 1.41030846 |
| 50 | MP0002722_abnormal_immune_system | 1.39188537 |
| 51 | MP0002429_abnormal_blood_cell | 1.35341817 |
| 52 | MP0008469_abnormal_protein_level | 1.34695063 |
| 53 | MP0010368_abnormal_lymphatic_system | 1.29858624 |
| 54 | MP0005164_abnormal_response_to | 1.28053649 |
| 55 | MP0003866_abnormal_defecation | 1.27829048 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.27423101 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.27406222 |
| 58 | MP0005671_abnormal_response_to | 1.26835669 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.26105335 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.26105335 |
| 61 | MP0000609_abnormal_liver_physiology | 1.24667131 |
| 62 | MP0004019_abnormal_vitamin_homeostasis | 1.19774307 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.16575595 |
| 64 | MP0008260_abnormal_autophagy | 1.15977031 |
| 65 | MP0003300_gastrointestinal_ulcer | 1.15077785 |
| 66 | MP0002420_abnormal_adaptive_immunity | 1.14493684 |
| 67 | MP0001819_abnormal_immune_cell | 1.14469868 |
| 68 | MP0008004_abnormal_stomach_pH | 1.12298276 |
| 69 | MP0004782_abnormal_surfactant_physiolog | 1.12026457 |
| 70 | MP0005334_abnormal_fat_pad | 1.11909405 |
| 71 | MP0004147_increased_porphyrin_level | 1.11298372 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.10634294 |
| 73 | MP0002118_abnormal_lipid_homeostasis | 1.10423908 |
| 74 | MP0003303_peritoneal_inflammation | 1.07943868 |
| 75 | MP0005409_darkened_coat_color | 1.06480696 |
| 76 | MP0000015_abnormal_ear_pigmentation | 1.05028931 |
| 77 | MP0000703_abnormal_thymus_morphology | 1.05017943 |
| 78 | MP0002090_abnormal_vision | 1.02872926 |
| 79 | MP0002653_abnormal_ependyma_morphology | 1.01572381 |
| 80 | MP0003279_aneurysm | 1.00506364 |
| 81 | MP0001986_abnormal_taste_sensitivity | 1.00019598 |
| 82 | MP0001663_abnormal_digestive_system | 0.99453989 |
| 83 | MP0003448_altered_tumor_morphology | 0.99351402 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96432425 |
| 85 | MP0001851_eye_inflammation | 0.96149969 |
| 86 | MP0009763_increased_sensitivity_to | 0.95497747 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 0.95184583 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 0.94531342 |
| 89 | MP0002168_other_aberrant_phenotype | 0.94161887 |
| 90 | MP0005076_abnormal_cell_differentiation | 0.92563027 |
| 91 | MP0001873_stomach_inflammation | 0.90901498 |
| 92 | MP0009115_abnormal_fat_cell | 0.90540805 |
| 93 | MP0005390_skeleton_phenotype | 0.90402514 |
| 94 | MP0004381_abnormal_hair_follicle | 0.89508325 |
| 95 | MP0000920_abnormal_myelination | 0.87600035 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.86892115 |
| 97 | MP0001666_abnormal_nutrient_absorption | 0.86778438 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.85821113 |
| 99 | MP0002295_abnormal_pulmonary_circulatio | 0.85470565 |
| 100 | MP0009278_abnormal_bone_marrow | 0.84399831 |
| 101 | MP0002396_abnormal_hematopoietic_system | 0.84076142 |
| 102 | MP0002332_abnormal_exercise_endurance | 0.82822011 |
| 103 | MP0005332_abnormal_amino_acid | 0.82599333 |
| 104 | MP0000716_abnormal_immune_system | 0.81330136 |
| 105 | MP0004947_skin_inflammation | 0.80767308 |
| 106 | MP0001727_abnormal_embryo_implantation | 0.79746987 |
| 107 | MP0003638_abnormal_response/metabolism_ | 0.79357293 |
| 108 | MP0005451_abnormal_body_composition | 0.79200611 |
| 109 | MP0005083_abnormal_biliary_tract | 0.77668447 |
| 110 | MP0002971_abnormal_brown_adipose | 0.75367558 |
| 111 | MP0003806_abnormal_nucleotide_metabolis | 0.74565077 |
| 112 | MP0000733_abnormal_muscle_development | 0.74361789 |
| 113 | MP0000858_altered_metastatic_potential | 0.74118794 |
| 114 | MP0002277_abnormal_respiratory_mucosa | 0.72653561 |
| 115 | MP0000689_abnormal_spleen_morphology | 0.72569953 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 0.71877972 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.71671072 |
| 118 | MP0000371_diluted_coat_color | 0.71185640 |
| 119 | MP0008438_abnormal_cutaneous_collagen | 0.69713393 |
| 120 | MP0002933_joint_inflammation | 0.69638333 |
| 121 | MP0005646_abnormal_pituitary_gland | 0.69150983 |
| 122 | MP0003632_abnormal_nervous_system | 0.68456241 |
| 123 | MP0000249_abnormal_blood_vessel | 0.67775054 |
| 124 | MP0010155_abnormal_intestine_physiology | 0.67648075 |
| 125 | MP0003646_muscle_fatigue | 0.64762336 |
| 126 | MP0000490_abnormal_crypts_of | 0.62719678 |
| 127 | MP0005075_abnormal_melanosome_morpholog | 0.62699559 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.61522343 |
| 129 | MP0008874_decreased_physiological_sensi | 0.59172390 |
| 130 | MP0002928_abnormal_bile_duct | 0.56825223 |
| 131 | MP0003795_abnormal_bone_structure | 0.55090589 |
| 132 | MP0002254_reproductive_system_inflammat | 0.54872685 |
| 133 | MP0003878_abnormal_ear_physiology | 0.53227557 |
| 134 | MP0005377_hearing/vestibular/ear_phenot | 0.53227557 |
| 135 | MP0001501_abnormal_sleep_pattern | 0.53112950 |
| 136 | MP0002166_altered_tumor_susceptibility | 0.52741451 |
| 137 | MP0003195_calcinosis | 0.52697505 |
| 138 | MP0005381_digestive/alimentary_phenotyp | 0.50841544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.44706373 |
| 2 | Complement deficiency (HP:0004431) | 6.76597321 |
| 3 | Glomerulonephritis (HP:0000099) | 6.70829952 |
| 4 | Eczematoid dermatitis (HP:0000976) | 6.08665819 |
| 5 | Stomatitis (HP:0010280) | 5.86896830 |
| 6 | Abnormality of complement system (HP:0005339) | 5.51058419 |
| 7 | Myocardial infarction (HP:0001658) | 4.98229494 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.96452097 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.70026793 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.25415662 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 4.22332281 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.21759070 |
| 13 | Xanthomatosis (HP:0000991) | 4.01779145 |
| 14 | Orchitis (HP:0100796) | 3.96456790 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 3.96258701 |
| 16 | Optic neuritis (HP:0100653) | 3.96258701 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.94047972 |
| 18 | Obstructive lung disease (HP:0006536) | 3.94047972 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.90020777 |
| 20 | Joint hemorrhage (HP:0005261) | 3.83641960 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.73098213 |
| 22 | Nephritis (HP:0000123) | 3.72541658 |
| 23 | Cerebral palsy (HP:0100021) | 3.62456890 |
| 24 | Neurofibrillary tangles (HP:0002185) | 3.60857052 |
| 25 | Vasculitis (HP:0002633) | 3.58505619 |
| 26 | Deep venous thrombosis (HP:0002625) | 3.46737138 |
| 27 | Arterial thrombosis (HP:0004420) | 3.45425516 |
| 28 | Urticaria (HP:0001025) | 3.40809266 |
| 29 | Hemoptysis (HP:0002105) | 3.36446532 |
| 30 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.29749467 |
| 31 | Osteolytic defects of the hand bones (HP:0009699) | 3.29749467 |
| 32 | Episodic fever (HP:0001954) | 3.27489286 |
| 33 | Polycythemia (HP:0001901) | 3.24094706 |
| 34 | Prolonged partial thromboplastin time (HP:0003645) | 3.24025322 |
| 35 | Myositis (HP:0100614) | 3.20900508 |
| 36 | Leukocytosis (HP:0001974) | 3.16638601 |
| 37 | Hypochromic microcytic anemia (HP:0004840) | 3.16289230 |
| 38 | Esophageal varix (HP:0002040) | 3.07129225 |
| 39 | Hypochromic anemia (HP:0001931) | 3.05106636 |
| 40 | Increased IgE level (HP:0003212) | 3.02008371 |
| 41 | Spontaneous hematomas (HP:0007420) | 3.00814386 |
| 42 | Abnormality of glycolipid metabolism (HP:0010969) | 3.00363591 |
| 43 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.00363591 |
| 44 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.00363591 |
| 45 | Abnormality of lateral ventricle (HP:0030047) | 2.98956437 |
| 46 | Recurrent skin infections (HP:0001581) | 2.98550942 |
| 47 | Cerebral hemorrhage (HP:0001342) | 2.97396841 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.92334755 |
| 49 | Increased IgM level (HP:0003496) | 2.89348252 |
| 50 | T lymphocytopenia (HP:0005403) | 2.89244117 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.88235610 |
| 52 | Abnormality of T cell number (HP:0011839) | 2.88008525 |
| 53 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.84279987 |
| 54 | Abnormal glucose tolerance (HP:0001952) | 2.78356888 |
| 55 | Cerebral inclusion bodies (HP:0100314) | 2.76696983 |
| 56 | Abnormality of the pleura (HP:0002103) | 2.73025157 |
| 57 | Intrahepatic cholestasis (HP:0001406) | 2.72017958 |
| 58 | Thrombophlebitis (HP:0004418) | 2.69347452 |
| 59 | Testicular atrophy (HP:0000029) | 2.65674858 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.65077551 |
| 61 | Colitis (HP:0002583) | 2.64552796 |
| 62 | Hypercholesterolemia (HP:0003124) | 2.63078748 |
| 63 | Peritonitis (HP:0002586) | 2.61419214 |
| 64 | Keratoconjunctivitis sicca (HP:0001097) | 2.60448884 |
| 65 | Recurrent viral infections (HP:0004429) | 2.60405857 |
| 66 | Abnormality of macrophages (HP:0004311) | 2.58284953 |
| 67 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.56606567 |
| 68 | Petechiae (HP:0000967) | 2.56460473 |
| 69 | Abnormal platelet function (HP:0011869) | 2.54314481 |
| 70 | Impaired platelet aggregation (HP:0003540) | 2.54314481 |
| 71 | Thick nail (HP:0001805) | 2.51118839 |
| 72 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.50287945 |
| 73 | Fetal akinesia sequence (HP:0001989) | 2.49975337 |
| 74 | Abnormality of T cells (HP:0002843) | 2.48583386 |
| 75 | Cellulitis (HP:0100658) | 2.48253101 |
| 76 | Axonal loss (HP:0003447) | 2.47910631 |
| 77 | Periodontitis (HP:0000704) | 2.46960999 |
| 78 | Fatigue (HP:0012378) | 2.45069756 |
| 79 | Pustule (HP:0200039) | 2.44997368 |
| 80 | Disproportionate tall stature (HP:0001519) | 2.44173797 |
| 81 | Autoimmune thrombocytopenia (HP:0001973) | 2.42882570 |
| 82 | Conjunctival telangiectasia (HP:0000524) | 2.42566661 |
| 83 | Mesangial abnormality (HP:0001966) | 2.40980883 |
| 84 | Granulocytopenia (HP:0001913) | 2.40520773 |
| 85 | Chronic otitis media (HP:0000389) | 2.36531791 |
| 86 | Hepatocellular carcinoma (HP:0001402) | 2.35269084 |
| 87 | Pulmonary embolism (HP:0002204) | 2.34624479 |
| 88 | Keratoconjunctivitis (HP:0001096) | 2.32302060 |
| 89 | Increased serum ferritin (HP:0003281) | 2.30288602 |
| 90 | Keratitis (HP:0000491) | 2.29814053 |
| 91 | Eosinophilia (HP:0001880) | 2.28527800 |
| 92 | Osteomyelitis (HP:0002754) | 2.28303134 |
| 93 | Epistaxis (HP:0000421) | 2.28180131 |
| 94 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.26926191 |
| 95 | Increased cerebral lipofuscin (HP:0011813) | 2.26528074 |
| 96 | Vertigo (HP:0002321) | 2.26423529 |
| 97 | Sepsis (HP:0100806) | 2.23204904 |
| 98 | Polyneuropathy (HP:0001271) | 2.22609893 |
| 99 | Recurrent cutaneous fungal infections (HP:0011370) | 2.20116439 |
| 100 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.20116439 |
| 101 | Loss of speech (HP:0002371) | 2.19431956 |
| 102 | Adactyly (HP:0009776) | 2.18815899 |
| 103 | Abnormality of the pericardium (HP:0001697) | 2.18523987 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 2.18311120 |
| 105 | Encephalitis (HP:0002383) | 2.17725518 |
| 106 | Hypergammaglobulinemia (HP:0010702) | 2.17148285 |
| 107 | Pulmonary infiltrates (HP:0002113) | 2.16162424 |
| 108 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15612326 |
| 109 | Mucopolysacchariduria (HP:0008155) | 2.15612326 |
| 110 | Thrombocytosis (HP:0001894) | 2.15568100 |
| 111 | Abnormality of the endocardium (HP:0004306) | 2.14389886 |
| 112 | Acne (HP:0001061) | 2.13556357 |
| 113 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.12878791 |
| 114 | Abnormality of T cell physiology (HP:0011840) | 2.12172223 |
| 115 | Disinhibition (HP:0000734) | 2.11707571 |
| 116 | Anorexia (HP:0002039) | 2.10629474 |
| 117 | Hematochezia (HP:0002573) | 2.10103156 |
| 118 | Amaurosis fugax (HP:0100576) | 2.09084292 |
| 119 | Hyperlipoproteinemia (HP:0010980) | 2.07862597 |
| 120 | Arterial tortuosity (HP:0005116) | 2.07486980 |
| 121 | Lymphopenia (HP:0001888) | 2.06944743 |
| 122 | Gingivitis (HP:0000230) | 2.06763208 |
| 123 | Purpura (HP:0000979) | 2.06100187 |
| 124 | Abnormality of the common coagulation pathway (HP:0010990) | 2.05920396 |
| 125 | Inflammation of the large intestine (HP:0002037) | 2.04932505 |
| 126 | Gastrointestinal inflammation (HP:0004386) | 2.04699391 |
| 127 | Arthropathy (HP:0003040) | 2.04205527 |
| 128 | Agnosia (HP:0010524) | 2.03812895 |
| 129 | Hepatosplenomegaly (HP:0001433) | 2.03054152 |
| 130 | Microcytic anemia (HP:0001935) | 2.02872122 |
| 131 | Abnormality of eosinophils (HP:0001879) | 2.01888079 |
| 132 | Amyloidosis (HP:0011034) | 1.99508189 |
| 133 | Glomerulopathy (HP:0100820) | 1.99307938 |
| 134 | Stomach cancer (HP:0012126) | 1.97349252 |
| 135 | Epidermoid cyst (HP:0200040) | 1.97271160 |
| 136 | Late onset (HP:0003584) | 1.95562746 |
| 137 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95232791 |
| 138 | Recurrent fungal infections (HP:0002841) | 1.95203750 |
| 139 | Hypoalphalipoproteinemia (HP:0003233) | 1.95200215 |
| 140 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94575929 |
| 141 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94575929 |
| 142 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94575929 |
| 143 | Recurrent pneumonia (HP:0006532) | 1.93989250 |
| 144 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.93479610 |
| 145 | Abnormality of the axillary hair (HP:0100134) | 1.91895877 |
| 146 | Abnormality of secondary sexual hair (HP:0009888) | 1.91895877 |
| 147 | Hemorrhage of the eye (HP:0011885) | 1.91259661 |
| 148 | Hypobetalipoproteinemia (HP:0003563) | 1.87872159 |
| 149 | Prostate neoplasm (HP:0100787) | 1.87726069 |
| 150 | Abnormality of the peritoneum (HP:0002585) | 1.84397163 |
| 151 | Premature loss of primary teeth (HP:0006323) | 1.84354234 |
| 152 | Meningitis (HP:0001287) | 1.83730698 |
| 153 | Cheilitis (HP:0100825) | 1.83014545 |
| 154 | Chest pain (HP:0100749) | 1.82614735 |
| 155 | Gingival bleeding (HP:0000225) | 1.82347035 |
| 156 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.82060421 |
| 157 | Gangrene (HP:0100758) | 1.81487566 |
| 158 | Panhypogammaglobulinemia (HP:0003139) | 1.79684292 |
| 159 | Hyperammonemia (HP:0001987) | 1.79474881 |
| 160 | Recurrent bronchitis (HP:0002837) | 1.79176426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 6.76817937 |
| 2 | GRK7 | 4.47061957 |
| 3 | SIK2 | 3.21391803 |
| 4 | STK10 | 3.01185465 |
| 5 | BLK | 2.95487875 |
| 6 | ZAP70 | 2.89298378 |
| 7 | MOS | 2.71040497 |
| 8 | RIPK4 | 2.49662750 |
| 9 | IRAK4 | 2.42379847 |
| 10 | TNK2 | 2.32575327 |
| 11 | GRK6 | 2.21025759 |
| 12 | YES1 | 2.15155874 |
| 13 | NEK9 | 2.11431844 |
| 14 | GRK5 | 2.11367188 |
| 15 | MAP3K14 | 2.09217015 |
| 16 | MAP4K1 | 2.08740309 |
| 17 | TAOK1 | 2.06229698 |
| 18 | EPHB1 | 2.05137793 |
| 19 | BTK | 1.98704565 |
| 20 | MAP3K11 | 1.90051997 |
| 21 | MAP3K3 | 1.83498515 |
| 22 | CDK9 | 1.78937957 |
| 23 | MAPKAPK5 | 1.73922988 |
| 24 | TYK2 | 1.68841413 |
| 25 | ERN1 | 1.63869680 |
| 26 | HCK | 1.59444334 |
| 27 | BMPR2 | 1.46573842 |
| 28 | TAOK3 | 1.33582110 |
| 29 | CDK6 | 1.33526560 |
| 30 | ADRBK2 | 1.33352142 |
| 31 | EIF2AK2 | 1.30307097 |
| 32 | TEC | 1.24880579 |
| 33 | CSK | 1.24678264 |
| 34 | SYK | 1.23627795 |
| 35 | ITK | 1.20750474 |
| 36 | JAK2 | 1.20024385 |
| 37 | LCK | 1.19567264 |
| 38 | PRPF4B | 1.19369975 |
| 39 | IKBKB | 1.17357691 |
| 40 | IRAK1 | 1.16341734 |
| 41 | MARK3 | 1.12775234 |
| 42 | MAP3K10 | 1.10713981 |
| 43 | JAK1 | 1.09826418 |
| 44 | TBK1 | 1.09507952 |
| 45 | SIK3 | 1.07584659 |
| 46 | MAP3K1 | 1.07365325 |
| 47 | MAP3K13 | 1.03562506 |
| 48 | TAOK2 | 0.99107372 |
| 49 | PKN1 | 0.95817187 |
| 50 | LYN | 0.95717522 |
| 51 | KIT | 0.91442426 |
| 52 | TXK | 0.91142723 |
| 53 | ABL1 | 0.90773179 |
| 54 | CSF1R | 0.88381733 |
| 55 | JAK3 | 0.88246182 |
| 56 | CAMK1D | 0.86960702 |
| 57 | IRAK2 | 0.86566870 |
| 58 | PRKD2 | 0.86352449 |
| 59 | FES | 0.84132862 |
| 60 | FGFR4 | 0.83821126 |
| 61 | MAPK11 | 0.80835883 |
| 62 | TTN | 0.79247833 |
| 63 | MAPK12 | 0.74731089 |
| 64 | EGFR | 0.74531489 |
| 65 | MARK2 | 0.73917124 |
| 66 | MAPK15 | 0.73456329 |
| 67 | IGF1R | 0.71907591 |
| 68 | IKBKE | 0.69665756 |
| 69 | CHUK | 0.68806552 |
| 70 | MAP2K4 | 0.68780535 |
| 71 | KSR2 | 0.68588233 |
| 72 | MAP2K6 | 0.68479071 |
| 73 | ACVR1B | 0.68321160 |
| 74 | PTK6 | 0.68299141 |
| 75 | CAMKK2 | 0.67959510 |
| 76 | MAP3K6 | 0.65450033 |
| 77 | IRAK3 | 0.64954888 |
| 78 | PTK2B | 0.64695197 |
| 79 | STK11 | 0.64287944 |
| 80 | PDK1 | 0.64259226 |
| 81 | MAPKAPK2 | 0.62780018 |
| 82 | MAP3K5 | 0.62478306 |
| 83 | PDPK1 | 0.61600016 |
| 84 | PRKCD | 0.61538326 |
| 85 | PRKCQ | 0.61536769 |
| 86 | FRK | 0.59743931 |
| 87 | TESK2 | 0.59009960 |
| 88 | MAP2K2 | 0.57953144 |
| 89 | CDC42BPA | 0.57900229 |
| 90 | ADRBK1 | 0.55299085 |
| 91 | PIK3CG | 0.53513836 |
| 92 | INSR | 0.53474958 |
| 93 | HIPK2 | 0.53414021 |
| 94 | PRKD1 | 0.53374900 |
| 95 | CDK19 | 0.52108536 |
| 96 | RPS6KA6 | 0.51230739 |
| 97 | FYN | 0.50338391 |
| 98 | ABL2 | 0.50322704 |
| 99 | PINK1 | 0.49386860 |
| 100 | PDGFRB | 0.47872020 |
| 101 | TLK1 | 0.46512351 |
| 102 | DYRK3 | 0.46395432 |
| 103 | MAPK7 | 0.45879560 |
| 104 | MAPK4 | 0.45586446 |
| 105 | RPS6KC1 | 0.44943323 |
| 106 | RPS6KL1 | 0.44943323 |
| 107 | DYRK1B | 0.44403417 |
| 108 | GSK3A | 0.44267693 |
| 109 | MAP3K7 | 0.42709777 |
| 110 | KDR | 0.41286325 |
| 111 | CLK1 | 0.40909996 |
| 112 | DAPK2 | 0.39479952 |
| 113 | TRPM7 | 0.38296049 |
| 114 | GRK1 | 0.37912388 |
| 115 | PAK4 | 0.36676079 |
| 116 | SCYL2 | 0.35700035 |
| 117 | PRKCZ | 0.35347084 |
| 118 | SRC | 0.34782099 |
| 119 | STK4 | 0.33457561 |
| 120 | MAP3K12 | 0.33099386 |
| 121 | MINK1 | 0.32734924 |
| 122 | NLK | 0.32379446 |
| 123 | SGK3 | 0.32342434 |
| 124 | EPHA3 | 0.32212100 |
| 125 | NEK2 | 0.31089692 |
| 126 | PIM1 | 0.31048251 |
| 127 | MAP2K3 | 0.30635452 |
| 128 | CAMKK1 | 0.29056936 |
| 129 | PRKACB | 0.29028364 |
| 130 | PRKACG | 0.28276552 |
| 131 | PRKAA2 | 0.27208400 |
| 132 | SIK1 | 0.26509372 |
| 133 | PBK | 0.25461539 |
| 134 | OXSR1 | 0.25204912 |
| 135 | MAP3K2 | 0.24716811 |
| 136 | MATK | 0.24466339 |
| 137 | LRRK2 | 0.23128294 |
| 138 | FGR | 0.20602345 |
| 139 | MST1R | 0.20032297 |
| 140 | PAK6 | 0.18948098 |
| 141 | FGFR3 | 0.18413864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.26176994 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.66270523 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.10662844 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.86866236 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.44798200 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.38821255 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.25970226 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.10327951 |
| 9 | Asthma_Homo sapiens_hsa05310 | 1.97438072 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.96851168 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.85591053 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.84629632 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.83964049 |
| 14 | Prion diseases_Homo sapiens_hsa05020 | 1.83676515 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.80816754 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.76842366 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.76012299 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.70627513 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69019837 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.63024017 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.53238225 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51554412 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.50572451 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.48213397 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.46345391 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.46142643 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.43984858 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.43889424 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42256520 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42181723 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.39049647 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36329733 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34010501 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.33141709 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.29676775 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.28434756 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.26766798 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.26153072 |
| 39 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.26133454 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24954368 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.20902414 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.19644212 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18851414 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12970751 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12576290 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.09960317 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.09080119 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05975127 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05584649 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 1.04968821 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02974432 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 1.00903129 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.99273561 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.98386571 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.98095542 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98087820 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94558084 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.93815586 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90309366 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89621512 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88108002 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87484373 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.87282594 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.87010142 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84003664 |
| 66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.82412874 |
| 67 | Measles_Homo sapiens_hsa05162 | 0.81383011 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.81252479 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81038800 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.80706070 |
| 71 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.79006675 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77800426 |
| 73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74317990 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 0.72505708 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70858775 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68687526 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68686916 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.68530826 |
| 79 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.67401442 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67353929 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64345072 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63592730 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62457080 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.61998098 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61861134 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60468138 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60264206 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59019583 |
| 89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58415349 |
| 90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57764134 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57496728 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57436840 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.57427453 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57413191 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56311800 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53800130 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53460331 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53037745 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52831719 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49010214 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48634229 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47150062 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43464411 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43363329 |
| 105 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43032171 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.42863229 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41737943 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40991936 |
| 109 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40942495 |
| 110 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.40594660 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.40582425 |
| 112 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.40509651 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40417522 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39589640 |
| 115 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39527583 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39399678 |
| 117 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.37973008 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37060744 |
| 119 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.36000469 |
| 120 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35639064 |
| 121 | Renin secretion_Homo sapiens_hsa04924 | 0.35237084 |
| 122 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.34522907 |
| 123 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34146605 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33719165 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33619370 |
| 126 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33557321 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32898532 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32451899 |
| 129 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31558477 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.31468245 |
| 131 | Hepatitis B_Homo sapiens_hsa05161 | 0.31318608 |
| 132 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31257880 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30936595 |
| 134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30205676 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30159444 |
| 136 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29811099 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.29240879 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29202019 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29074074 |
| 140 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.26189827 |
| 141 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25694766 |
| 142 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.25282239 |
| 143 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.24812806 |
| 144 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24021939 |
| 145 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.23328860 |
| 146 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.22086124 |
| 147 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.21648801 |
| 148 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21373476 |
| 149 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20961775 |
| 150 | Morphine addiction_Homo sapiens_hsa05032 | 0.16640832 |

